Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

221 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Usefulness of coronary fractional flow reserve measurements in guiding clinical decisions in intermediate or equivocal left main coronary stenoses.
Courtis J, Rodés-Cabau J, Larose E, Potvin JM, Déry JP, Larochellière RD, Côté M, Cousterousse O, Nguyen CM, Proulx G, Rinfret S, Bertrand OF. Courtis J, et al. Among authors: rinfret s. Am J Cardiol. 2009 Apr 1;103(7):943-9. doi: 10.1016/j.amjcard.2008.11.054. Epub 2009 Feb 7. Am J Cardiol. 2009. PMID: 19327420
Comparison of outcomes in patients > or =70 years versus <70 years after transradial coronary stenting with maximal antiplatelet therapy for acute coronary syndrome.
Bagur R, Bertrand OF, Rodés-Cabau J, Rinfret S, Larose E, Tizón-Marcos H, Gleeton O, Nguyen CM, Roy L, Costerousse O, De Larochellière R. Bagur R, et al. Among authors: rinfret s. Am J Cardiol. 2009 Sep 1;104(5):624-9. doi: 10.1016/j.amjcard.2009.04.050. Epub 2009 Jun 24. Am J Cardiol. 2009. PMID: 19699334 Clinical Trial.
A multicentre, randomized, double-blind placebo-controlled trial evaluating rosiglitazone for the prevention of atherosclerosis progression after coronary artery bypass graft surgery in patients with type 2 diabetes. Design and rationale of the VeIn-Coronary aTherOsclerosis and Rosiglitazone after bypass surgerY (VICTORY) trial.
Bertrand OF, Poirier P, Rodés-Cabau J, Rinfret S, Title L, Dzavik V, Natarajan M, Angel J, Batalla N, Alméras N, Costerousse O, De Larochellière R, Roy L, Després JP; VICTORY trial investigators. Bertrand OF, et al. Among authors: rinfret s. Can J Cardiol. 2009 Sep;25(9):509-15. doi: 10.1016/s0828-282x(09)70136-9. Can J Cardiol. 2009. PMID: 19746240 Free PMC article. Clinical Trial.
Comparison of plaque sealing with paclitaxel-eluting stents versus medical therapy for the treatment of moderate nonsignificant saphenous vein graft lesions: the moderate vein graft lesion stenting with the taxus stent and intravascular ultrasound (VELETI) pilot trial.
Rodés-Cabau J, Bertrand OF, Larose E, Déry JP, Rinfret S, Bagur R, Proulx G, Nguyen CM, Côté M, Landcop MC, Boudreault JR, Rouleau J, Roy L, Gleeton O, Barbeau G, Noël B, Courtis J, Dagenais GR, Després JP, DeLarochellière R. Rodés-Cabau J, et al. Among authors: rinfret s. Circulation. 2009 Nov 17;120(20):1978-86. doi: 10.1161/CIRCULATIONAHA.109.874057. Epub 2009 Nov 2. Circulation. 2009. PMID: 19884468 Clinical Trial.
221 results